pembrolizumab,pds0101
pds biotech,merck
['pds bio']
pds biotechnology post-asco conference call tomorrow, june 6, at 8 a.m. et #stocksoftheday #stockalert #stocknews #cancer #conferencecall #positiveclinicaltrialresults 
Find the most important news and press releases about U.S. publicly-traded companies in real-time and stay ahead of the game!